InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by Venkatesan Jay, Directeur. Director active across 3 companies, notably ALPINE IMMUNE SCIENCES, INC.. Cumulatively, 13 reports have been published. Total volume traded: €6.9m. The latest transaction was filed on 9 February 2021 — X. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
€13,19711,313 shares@ €1.16650.4% of flow
Common Stock
SEC:0001601485-22-000043:0·
Ideal exit: 19 Feb 2023 (T+270)
€2m396,329 shares@ €5.334559.1% of flow
Common Stock
SEC:0001601485-22-000045:0·
€58,13450,000 shares@ €1.16271.6% of flow
Common Stock
SEC:0001601485-22-000039:0·
Ideal exit: 14 Feb 2023 (T+270)
€150,57966,907 shares@ €2.250621.6% of flow
Common Stock
SEC:0001601485-21-000095·
Ideal exit: 23 Sept 2022 (T+270)
€150,57966,907 shares@ €2.25064.2% of flow
Common Stock
SEC:0001601485-21-000095:0·
Ideal exit: 23 Sept 2022 (T+270)
€7,9833,527 shares@ €2.26341.1% of flow
Common Stock
SEC:0001601485-21-000093·
Ideal exit: 16 Sept 2022 (T+270)
€7,9833,527 shares@ €2.26340.2% of flow
Common Stock
SEC:0001601485-21-000093:0·
Ideal exit: 16 Sept 2022 (T+270)
€62,87727,883 shares@ €2.2559.0% of flow
Common Stock
SEC:0001601485-21-000089·
Ideal exit: 12 Sept 2022 (T+270)
€62,87727,883 shares@ €2.2551.8% of flow
Common Stock
SEC:0001601485-21-000089:0·
Ideal exit: 12 Sept 2022 (T+270)
€474,61741,091 shares@ €11.550468.2% of flow
Common Stock
SEC:0001601485-21-000087·
€474,61741,091 shares@ €11.550413.3% of flow
Common Stock
SEC:0001601485-21-000087:0·
€3m400,000 shares@ €7.9881100.0% of flow
Common Stock
SEC:0001626199-21-000113·
€3m400,000 shares@ €7.988150.0% of flow
Common Stock
SEC:0001626199-21-000113:0·
13 of 13 declarations
About Venkatesan Jay
Jay Venkatesan is a Director at Alpine Immune Sciences, Inc. and Angion Biomedica Corp. He brings his expertise to the board, contributing to the strategy and direction of both companies.
